Inflammatory markers of CHMP2B-mediated frontotemporal dementia

Ahmed, 2007, Progranulin in frontotemporal lobar degeneration and neuroinflammation, J. Neuroinflamm., 4, 7, 10.1186/1742-2094-4-7 Alcolea, 2014, Relationship between beta-secretase, inflammation and core cerebrospinal fluid biomarkers for alzheimer’s disease, J. Alzheimer’s Dis., 42, 157, 10.3233/JAD-140240 Aversa, 2004, Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat, J. Neurovirol., 10, 86, 10.1080/13550280490279807 Bang, 2015, Frontotemporal dementia, Lancet, 386, 1672, 10.1016/S0140-6736(15)00461-4 Bonotis, 2008, Systemic immune aberrations in Alzheimer’s disease patients, J. Neuroimmunol., 193, 183, 10.1016/j.jneuroim.2007.10.020 Borroni, 2014, Heterozygous TREM2 mutations in frontotemporal dementia, Neurobiol. Aging, 35, 934.e7, 10.1016/j.neurobiolaging.2013.09.017 Bossù, 2011, Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients, J. Neuroinflamm., 8, 65, 10.1186/1742-2094-8-65 Brodaty, 2012, Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia, Int. Psychogeriatr., 24, 1034, 10.1017/S1041610211002924 Brown, 1995, Familial non-specific dementia maps to chromosome 3, Hum. Mol. Genet., 4, 1625, 10.1093/hmg/4.9.1625 Clayton, 2015, Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology, Acta Neuropathol., 130, 511, 10.1007/s00401-015-1475-3 Clayton, 2017, Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation, Hum. Mol. Genet., 26 Feuerstein, 1994, Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha, Cerebrovasc. Brain Metabol. Rev., 6, 341 Galimberti, 2008, Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer’s disease and frontotemporal lobar degeneration, J. Neurol., 539, 10.1007/s00415-008-0737-6 Galimberti, 2006, Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration, Neurology, 66, 146, 10.1212/01.wnl.0000191324.08289.9d Galimberti, 2015, Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers, Brain Behav. Immun., 6 Ghazi-Noori, 2012, Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice, Brain, 135, 819, 10.1093/brain/aws006 Gibbons, 2015, Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration, Neurobiol. Aging, 36, 10.1016/j.neurobiolaging.2014.10.023 Guerreiro, 2013, Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia–like syndrome without bone involvement, JAMA Neurol., 70, 78, 10.1001/jamaneurol.2013.579 Gydesen, 2002, Chromosome 3 linked frontotemporal dementia (FTD-3), Neurology, 59, 1585, 10.1212/01.WNL.0000034763.54161.1F Holm, 2007, A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3, J. Neuropathol. Exp. Neurol., 66, 884, 10.1097/nen.0b013e3181567f02 Jay, 2017, TREM2 in neurodegenerative diseases, Mol. Neurodegener., 12, 56, 10.1186/s13024-017-0197-5 Kleinberger, 2014, TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis, Sci. Transl. Med., 6, 10.1126/scitranslmed.3009093 del Campo, 2012, Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update, Biomark. Med., 6, 419, 10.2217/bmm.12.46 Lee, 2007, ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration, Curr. Biol., 17, 1561, 10.1016/j.cub.2007.07.029 Letendre, 1999, Cerebrospinal fluid b chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1, J. Infect. Dis., 180, 310, 10.1086/314866 Martens, 2012, Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury, J. Clin. Investig., 122, 3955, 10.1172/JCI63113 Miller, 2013, TDP-43 frontotemporal lobar degeneration and autoimmune disease, J. Neurol. Neurosurg. Psychiatry, 84, 956, 10.1136/jnnp-2012-304644 Nielsen, 2012, Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference, J. Gene Med., 14, 521, 10.1002/jgm.2649 Onyike, 2013, The epidemiology of frontotemporal dementia, Int. Rev. Psychiatry, 25, 130, 10.3109/09540261.2013.776523 Paulson, 2011, Genetics of dementia, Genet. Dement., 31, 449 Piccio, 2008, Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation, Brain, 131, 3081, 10.1093/brain/awn217 Piccio, 2016, Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status, Acta Neuropathol., 131, 925, 10.1007/s00401-016-1533-5 Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 134, 2456, 10.1093/brain/awr179 Rentzos, 2006, IL-15 Is elevated in cerebrospinal fluid of patients with alzheimer’s disease and frontotemporal dementia, J. Geriatr. Psychiatry Neurol., 19, 114, 10.1177/0891988706286226 Rentzos, 2006, Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia, J. Neurol. Sci., 249, 110, 10.1016/j.jns.2006.05.063 Rohrer, 2009, The heritability and genetics of frontotemporal lobar degeneration, Neurology, 73, 1451, 10.1212/WNL.0b013e3181bf997a Rosso, 2003, Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study, Brain, 126, 2016, 10.1093/brain/awg204 Rostgaard, 2018, CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers, Neurology, 90, e157, 10.1212/WNL.0000000000004799 Sjögren, 2004, Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications, J. Neurol. Neurosurg. Psychiatry, 75, 1107, 10.1136/jnnp.2003.019422 Skibinski, 2005, Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia, Nat. Genet., 37, 806, 10.1038/ng1609 Stokholm, 2009, Validation of the danish Addenbrooke’s cognitive examination as a screening test in a memory clinic, Dement. Geriatr. Cognit. Disord., 27, 361, 10.1159/000209271 Stokholm, 2013, Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study, J. Neurol. Neurosurg. Psychiatry, 84, 170, 10.1136/jnnp-2012-303813 Suárez-Calvet, 2016, sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers, EMBO Mol. Med., 8, 466, 10.15252/emmm.201506123 Teunissen, 2016, Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics, Alzheimer’s Dement., 2, 86 Urwin, 2009, The role of CHMP2B in frontotemporal dementia, Biochem. Soc. Trans., 37, 208, 10.1042/BST0370208 Urwin, 2010, Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations, Hum. Mol. Genet., 19, 2228, 10.1093/hmg/ddq100 Vieira, 2013, Epidemiology of early-onset dementia: a review of the literature, Clin. Pract. Epidemiol. Ment. Health, 9, 88, 10.2174/1745017901309010088 Zhang, 2017, Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B, Stem Cell Rep., 8, 648, 10.1016/j.stemcr.2017.01.012